Dietary carbohydrate substrates in the gastrointestinal lumen

Dietary carbohydrate substrates in the gastrointestinal lumen encompass the broad range of polysaccharides, oligosaccharides, and disaccharides consumed as part of the human diet. These molecules serve as the primary exogenous source of glucose, which is essential for cellular energy production and metabolic homeostasis (NIH, 2023). The digestion of these substrates is a multi-step process involving enzymes such as pancreatic alpha-amylase and intestinal brush-border alpha-glucosidases, which hydrolyze complex chains into simple, absorbable monosaccharides like glucose and fructose (PubMed, 2019). In the management of metabolic disorders, particularly Type 2 diabetes mellitus, these substrates are the indirect focus of pharmacological therapy. Drugs known as alpha-glucosidase inhibitors (e.g., acarbose) target the enzymes that process these carbohydrates, thereby slowing their digestion and reducing the rate of glucose absorption into the systemic circulation (StatPearls, 2023). This mechanism effectively blunts postprandial hyperglycemia, though it may lead to gastrointestinal side effects due to the fermentation of undigested carbohydrates by colonic bacteria.

Other names

Dietary carbohydratesLuminal carbohydratesComplex carbohydratesPolysaccharidesDisaccharides

Inhibition of enzymes such as alpha-glucosidase and alpha-amylase to delay the hydrolysis of complex carbohydrates into absorbable monosaccharides (StatPearls, 2023).